Can grade I diastolic dysfunction be used as a criterion for Stage B chronic heart failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Grade I Diastolic Dysfunction and Stage B Heart Failure Classification

Grade I diastolic dysfunction alone is generally NOT sufficient to classify a patient as Stage B heart failure, unless accompanied by other structural heart disease or evidence of elevated filling pressures.

Understanding Stage B Heart Failure Criteria

According to the most recent ACC/AHA guidelines, Stage B heart failure requires structural heart disease without current or prior symptoms 1. The 2022 guidelines specifically define Stage B as requiring one of the following 1:

  • Structural heart disease (ventricular hypertrophy, chamber enlargement, wall motion abnormalities, valvular disease)
  • Reduced left or right ventricular systolic function (reduced ejection fraction, reduced strain)
  • Evidence of increased filling pressures (by invasive hemodynamics or noninvasive imaging)
  • Risk factors PLUS elevated natriuretic peptides or persistently elevated cardiac troponin (in absence of competing diagnoses)

The Problem with Grade I Diastolic Dysfunction

Grade I diastolic dysfunction represents impaired relaxation with normal filling pressures 2. By definition, this means:

  • E/A ratio ≤0.8 with peak E velocity ≤50 cm/s
  • Normal left atrial pressure
  • No evidence of elevated filling pressures

The 2016 ASE/EACVI guidelines explicitly state that when E/A ≤0.8 with peak E velocity ≤50 cm/s, left atrial pressure is either normal or low 2. This contradicts the Stage B requirement for structural abnormality or elevated filling pressures.

Important Clinical Nuances

Grade Ia: The Exception That Proves the Rule

Recent research has identified a subset called "Grade Ia" diastolic dysfunction - patients with relaxation abnormality (E/A <0.8) BUT with elevated filling pressures (septal E/e' ≥15, lateral E/e' ≥12) 3. These patients WOULD qualify for Stage B heart failure because they demonstrate evidence of increased filling pressures despite the impaired relaxation pattern.

When Grade I DD Does Indicate Stage B

Grade I diastolic dysfunction qualifies as Stage B when it occurs in the context of:

  1. Documented structural heart disease (LV hypertrophy, chamber enlargement, regional wall motion abnormalities) 1
  2. Post-myocardial infarction - even with normal EF 4
  3. Known cardiomyopathy (hypertrophic, restrictive, infiltrative) 4, 5, 4
  4. Elevated biomarkers (BNP/NT-proBNP or troponin) in appropriate clinical context 1

Practical Clinical Algorithm

To determine if a patient with Grade I DD has Stage B HF:

  1. Assess for structural heart disease:

    • LV hypertrophy (increased LV mass index)
    • Chamber enlargement (LA volume index >34 mL/m²)
    • Wall motion abnormalities
    • Valvular disease
  2. Look for elevated filling pressures despite Grade I pattern:

    • Septal e' <7 cm/s or lateral e' <10 cm/s
    • Average E/e' >14
    • LA volume index >34 mL/m²
    • TR velocity >2.8 m/s
    • If ≥2 of these are present, consider "Grade Ia" → Stage B 3
  3. Check biomarkers:

    • Elevated BNP/NT-proBNP
    • Persistently elevated troponin (without ACS)
  4. Review clinical history:

    • Prior MI (automatic Stage B regardless of current function) 4
    • Cardiotoxic chemotherapy exposure 1
    • Known cardiomyopathy

Evidence Strength and Limitations

The 2001 ACC/AHA guidelines 4 focused Stage B on "left ventricular dysfunction" - primarily systolic dysfunction or post-MI patients. The guidelines acknowledged diastolic dysfunction but did not clearly delineate when isolated diastolic abnormalities constitute Stage B 4, 5, 4.

The 2022 guidelines 1 are more explicit, requiring either structural disease OR evidence of elevated filling pressures. Since Grade I DD by definition has normal filling pressures 2, it doesn't meet Stage B criteria unless other structural abnormalities coexist.

Recent prospective data 6 found that among ED patients with cardiovascular risk factors, 59.8% had undiagnosed Stage B HF, with 89.6% having isolated diastolic dysfunction. However, this study included Grade II and III diastolic dysfunction (which DO have elevated filling pressures), not just Grade I.

Common Pitfalls to Avoid

  • Don't assume all diastolic dysfunction equals Stage B - Grade I with truly normal filling pressures and no structural disease remains Stage A
  • Don't miss "Grade Ia" - patients with E/A <0.8 but elevated E/e' ratios have elevated filling pressures and ARE Stage B 3, 7
  • Don't ignore LA enlargement - LA volume index >34 mL/m² indicates chronic elevated pressures and structural remodeling, qualifying for Stage B even with Grade I pattern 2
  • Remember post-MI patients are automatically Stage B regardless of current diastolic function grade 4

References

Research

Ia diastolic dysfunction: an echocardiographic grade.

Echocardiography (Mount Kisco, N.Y.), 2015

Related Questions

What is grade 1 diastolic dysfunction (impaired relaxation)?
What is the management strategy for patients with Type B pre-heart failure (pre-hf)?
Is grade 1 diastolic dysfunction typically associated with elevated left atrial filling pressure?
How should the initial cardiac magnetic resonance (CMR) be interpreted and managed in a patient with a markedly dilated left ventricle (LV) and severely reduced left‑ventricular ejection fraction (EF) of 13 %, mild right‑ventricular (RV) dysfunction, no mitral or aortic regurgitant jet, subtle T2‑weighted and native T1‑mapping signal changes likely due to a small pericardial effusion and myocardial thinning, and absence of late gadolinium enhancement (LGE)?
How can I explain mild concentric hypertrophy and grade 1 diastolic dysfunction to a patient?
What is the appropriate treatment for an unknown non‑corrosive poisoning?
What is microcytosis?
What postoperative antibiotic regimen is recommended after a laparoscopic cholecystectomy, and when are additional antibiotics indicated?
What over‑the‑counter antifungal/dandruff regimen is appropriate for a patient with dry, flaky, itchy scalp, beard, and mustache who is already using clotrimazole 1% cream for a groin infection?
When should a metallo‑β‑lactamase (MBL)‑producing Enterobacter cloacae infection be suspected?
What medication regimen is appropriate for a 72‑year‑old woman with sudden vision loss, acute right frontal lobe cortex and right putamen infarcts on magnetic resonance imaging, a chronic right cerebellar infarct, a left internal carotid artery aneurysm, and documented in‑vitro aspirin responsiveness?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.